Levin Capital Strategies’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-22,500
| Closed | -$70.7K | – | 252 |
|
|
2023
Q3 | $70.7K | Sell |
22,500
-10,000
| -31% | -$31.4K | 0.01% | 217 |
|
|
2023
Q2 | $168K | Sell |
32,500
-175,124
| -84% | -$904K | 0.02% | 203 |
|
|
2023
Q1 | $1.09M | Sell |
207,624
-63,068
| -23% | -$332K | 0.14% | 76 |
|
|
2022
Q4 | $761K | Buy |
270,692
+14,848
| +6% | +$41.7K | 0.1% | 95 |
|
|
2022
Q3 | $1.06M | Buy |
255,844
+123,190
| +93% | +$511K | 0.14% | 78 |
|
|
2022
Q2 | $533K | Buy |
+132,654
| New | +$533K | 0.06% | 114 |
|
|
2020
Q3 | – | Sell |
-73,678
| Closed | -$614K | – | 283 |
|
|
2020
Q2 | $614K | Buy |
73,678
+43,678
| +146% | +$364K | 0.08% | 95 |
|
|
2020
Q1 | $148K | Sell |
30,000
-15,000
| -33% | -$74K | 0.02% | 141 |
|
|
2019
Q4 | $178K | Buy |
+45,000
| New | +$178K | 0.02% | 188 |
|